Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AI/ML Innovations Inc AIMLF


Primary Symbol: C.AIML

Technology Scientific & Technical Instruments
AI/ML Innovations Inc. business operations is aligned to capitalize on the areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive healthcare management solutions and precision support delivery across the health continuum. Its Salu Design Inc... see more

Recent & Breaking News (CSE:AIML)

AI/ML Innovations' Tech2Heal Starts Medical Device ISO 13485 Certification Process

Accesswire June 22, 2022

AI/ML Innovations' Tech2Heal Chosen as a Finalist in the i-Nov Innovation Contest

Accesswire June 9, 2022

AI/ML Innovations Engages Octagon Media/Wall Street Reporter for Market Awareness and Announces Stock Option Grant

Accesswire May 4, 2022

AI/ML Innovations' Health Gauge Licenses its Patented Technology to MedWatch Technologies, Inc.

Accesswire March 28, 2022

AI/ML Innovations Inc. Completes Financing for Total Gross Proceeds of $600,000.00

Accesswire March 24, 2022

AI/ML Innovations' Tech2Heal Selected for Prestigious Health Tech Campus

Accesswire February 7, 2022

AI/ML Innovations' Health Gauge Granted US Patent

Accesswire February 1, 2022

AI/ML Innovations' Tech2Heal Chosen for Mental Health Innovation Accelerator Program

Accesswire January 27, 2022

AI/ML Innovations' Health Gauge Licenses Its Technology for a B2B COVID Rapid Testing Solution

Accesswire November 4, 2021

AI/ML Innovations Announces Results of Warrant Early Exercise Incentive Program

Accesswire October 13, 2021

AI/ML Innovations' AI Rx Preparing for Imminent Launch into US Market

Accesswire October 12, 2021

AI/ML Innovations' Tech2Heal Readies Its Remote Patient Monitoring Platform For Deployment

Accesswire September 28, 2021

AI/ML Innovations Completes Transaction to Acquire Significant Interest in Digital Mental Health Provider, Tech2Heal

Accesswire September 23, 2021

AI/ML's Health Gauge Collaborates with Trinity Western University ("TWU") to Validate the Use of the HG Solution for Performance Athletics Programs

Accesswire September 9, 2021

AI/ML Innovations' Health Gauge Partners with AI-on-Call to Deploy an Acute Illness Early Diagnosis Solution

Accesswire September 7, 2021

AI/ML Introduces Its Digital Mental Health Subsidiary - AI Rx Inc.

Accesswire August 30, 2021

AI/ML Innovations Announces Early Exercise Warrant Incentive Program

TheNewsWire August 27, 2021

AI/ML's Health Gauge Forges Key Industry Relationships

Accesswire August 26, 2021

AI/ML Innovations Announces Listing on Frankfurt Stock Exchange

TheNewsWire August 20, 2021

AI/ML Innovations Inc. Announces Commencement of Trading on the OTCQB Venture Market in the United States

PR Newswire June 1, 2021